$6.68
0.7212.08%
Last update: Oct 9, 6:16 PM
$6.83
0.8714.6%
GT Biopharma Inc (GTBP) Stock Price, Quote, News & History
GTBPNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of GT Biopharma (NASDAQ:GTBP) through any online brokerage.
Other companies in GT Biopharma’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
GT Biopharma has a consensus price target of $275.00.
The stock price for GT Biopharma (NASDAQ: GTBP) is $6.83 last updated October 9, 2026 at 6:16 PM EDT.
There are no upcoming dividends for GT Biopharma.
GT Biopharma does not have any upcoming earnings scheduled.
There is no upcoming split for GT Biopharma.
GT Biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
GT Biopharma Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel immuno-oncology products in the United States. The company is engaged in discovering, developing, and commercializing...
